GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,555.20p
   
  • Change Today:
      5.20p
  • 52 Week High: 1,846.00p
  • 52 Week Low: 1,374.60p
  • Currency: UK Pounds
  • Shares Issued: 5,017m
  • Volume: 4,208,839
  • Market Cap: £78,030m
  • RiskGrade: 129

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart (07-08-2020)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 5.1% 5.2%
Div Cover 1.5 1.5
Op Mrgn 20.6% 23.9%
ROCE 59.5%  
Latest F'cast
P/E 12.6 13.4
PEG 3.3 n/a
Pr/Revenue 2.3 2.2
Pr/Book 4.3  
Latest F'cast
Revenue 9.5% 4.5%
PBT 29.6% 35.8%
EPS 3.8% -6.0%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 35,265.97 8,445.31 116.45p 13.4 n/a -6% 80.00p 5.2%
31-Dec-21 36,414.12 8,758.97 119.39p 13.0 5.1 +2% 80.07p 5.2%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

US FDA approves GSK’s BLENREP for multiple... 06-Aug-2020 07:00 RNS
Total Voting Rights 03-Aug-2020 11:31 RNS
Sanofi/GSK to supply EU with 300m COVID 19 doses 03-Aug-2020 07:00 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
27-Jul-20 Transfer From Emma Walmsley 0.000p 277,623 £0.00
13-Jul-20 Buy Dividends Iain Mackay 1,592.80p 426 £6,785.33
13-Jul-20 Buy Dividends Emma Walmsley 1,592.80p 2,203 £35,089.38

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,555.20p
Change Today 5.20p
% Change 0.34 %
52 Week High 1,846.00p
52 Week Low 1,374.60p
Volume 4,208,839
Shares Issued 5,017m
Market Cap £78,030m
RiskGrade 129

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.15% below the market average26.15% below the market average26.15% below the market average26.15% below the market average26.15% below the market average
96.43% above the sector average96.43% above the sector average96.43% above the sector average96.43% above the sector average96.43% above the sector average
Price Trend
16.47% above the market average16.47% above the market average16.47% above the market average16.47% above the market average16.47% above the market average
36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average
Income
78.87% above the market average78.87% above the market average78.87% above the market average78.87% above the market average78.87% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
36.73% above the market average36.73% above the market average36.73% above the market average36.73% above the market average36.73% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

What The Brokers Say

Strong Buy 7
Buy 2
Neutral 10
Sell 0
Strong Sell 2
Total 21
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q2 Q1
Ex-Div 13-Aug-20 14-May-20
Paid 08-Oct-20 09-Jul-20
Amount 19.00p 19.00p

Trades for 07-Aug-2020

Time Volume / Share Price
16:50 78 @ 1,553.40p
16:50 1,286 @ 1,553.40p
16:35 1,667,539 @ 1,555.20p
16:29 10 @ 1,554.20p
16:29 115 @ 1,554.00p

GlaxoSmithKline Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page